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Background: Influenza	 virus	 circulation	 is	 monitored	 through	 the	 Cambodian	 in-
fluenza-like	 illness	 (ILI)	 sentinel	 surveillance	 system	 and	 isolates	 are	 characterized	
by	 the	 National	 Influenza	 Centre	 (NIC).	 Seasonal	 influenza	 circulation	 has	 previ-
ously	been	characterized	by	year-round	activity	and	a	peak	during	the	rainy	season	
(June-November).
Objectives: We	documented	the	circulation	of	seasonal	 influenza	 in	Cambodia	 for	
2012-2015	and	investigated	genetic,	antigenic,	and	antiviral	resistance	characteris-
tics	of	influenza	isolates.
Patients/Methods: Respiratory	 samples	 were	 collected	 from	 patients	 presenting	
with	influenza-like	illness	(ILI)	at	11	hospitals	throughout	Cambodia.	First-line	screen-
ing	was	conducted	by	the	National	Institute	of	Public	Health	and	the	Armed	Forces	
Research	 Institute	 of	Medical	 Sciences.	Confirmation	of	 testing	 and	 genetic,	 anti-
genic	 and	antiviral	 resistance	characterization	was	conducted	by	 Institute	Pasteur	
in	Cambodia,	the	NIC.	Additional	virus	characterization	was	conducted	by	the	WHO	
Collaborating	Centre	for	Reference	and	Research	on	Influenza	(Melbourne,	Australia).
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1  | BACKGROUND
Influenza	 viruses	 belong	 to	 the	Orthomyxoviridae	 family	 of	 envel-
oped,	 segmented	 negative-stranded	 RNA	 viruses.	 Currently,	 four	
antigenically	 distinct	 influenza	 viruses	 are	 responsible	 for	 human	
seasonal	influenza	infections,	including	two	subtypes	of	influenza	A	
[A(H1N1)pdm09	and	A(H3N2)]	and	two	lineages	of	influenza	B	(B/
Yamagata	and	B/Victoria).	 Influenza	 is	 responsible	 for	a	 large	pro-
portion	of	human	morbidity	and	mortality	as	a	result	of	 infections	
worldwide.	 Annual	 influenza	 infections	 are	 estimated	 to	 result	 in	
approximately	 3	 to	 5	million	 cases	 of	 severe	 illness	 globally,1 and 
290	000	to	650	000	deaths.2
Seasonal	influenza	epidemics	occur	every	year	in	temperate	re-









We	 have	 previously	 described	 the	 circulation	 and	 seasonal-
ity	 of	 influenza	 viruses	 in	 Cambodia	 during	 six	 consecutive	 years	
(2006-2011)	following	the	establishment	of	the	Cambodian	National	
Influenza	 Centre	 (NIC)	 in	 2006.8-10	 These	 previous	 data	 demon-
strated	a	peak	in	influenza	circulation	during	the	rainy	season	from	
June	 to	 November,	 which	 is	 consistent	 with	 influenza	 circulation	
in	 the	 southern	 hemisphere.	However,	 year-round	 circulation	was	
also	 described,	 characteristic	 of	 influenza	 seasonality	 in	 tropical/





2  | MATERIAL S AND METHODS
2.1 | Ethical statement
The	 Cambodian	 ILI	 surveillance	 system	 is	 a	 public	 health	 activity	
managed	by	 the	Ministry	of	Health	 in	Cambodia	and	has	a	 stand-





than	15.5	million	people,	 situated	 in	 the	southwestern	part	of	 the	
Indochina	peninsula	and	sharing	international	borders	with	Thailand	
and	 Laos	 on	 the	West	 and	 North,	 and	 Vietnam	 on	 the	 East	 and	
Southeast.13	The	country	 is	affected	by	the	Asian	monsoon	and	 is	
mostly	hot	and	humid	with	a	mean	temperature	of	27ºC	and	mean	
relative	 humidity	 of	 77.5%.	 Similar	 to	 other	 subtropical/tropical	
areas,	 Cambodia	 has	 two	 distinct	 seasons:	 the	 dry	 season,	 which	
generally	runs	from	November	to	April;	and	the	rainy	season,	which	
starts	in	May-June	and	ends	in	October-November.
2.3 | ILI surveillance system in Cambodia
The	 Cambodian	 National	 Influenza	 Center	 (NIC)	 was	 established	
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western	Cambodia)	and	 in	 the	national	pediatric	hospital	 in	Phnom	
















veillance	 data	 were	 collected	 from	 a	 subset	 of	 outpatients	 pre-





were	 first	 screened	by	 the	 laboratories	 at	NIPH	or	AFRIMS	 and	
then	influenza-positive	samples	 (plus	~30%	negative	samples	for	



















Influenza‐positive samples Successful influenza isolationa,b Isolates sent to WHO CC
H1N1pdm09 H3N2
Influenza 





2012 1907c 26 218 80 324 6 88 50 0 37 1
2013 467 91 24 220 335 63 9 154 55 7 51
2014 404 36 212 15 263 33 174 11 11 30 3
2015 444 19 230 67 316 13 123 61 7 21 10
















Influenza	 viruses	were	 isolated	 at	 the	 IPC	 laboratory	 by	 inoc-










2.6 | Genome sequencing and phylogenetic analysis
Viral	RNA	extracted	from	MDCK	supernatant	was	used	to	sequence	
the	 HA	 gene	 of	 all	 influenza	 isolates	 at	 the	 NIC	 laboratory	 using	
Sanger	sequencing.	At	the	WHOCC	(Melbourne),	a	single-reaction,	
F I G U R E  2  Number	of	specimens	positive	for	influenza	by	subtype	in	Cambodia	2012-2015	by	week.	Cambodian	data	
accessed	from	the	Global	Initiative	on	Sharing	All	Influenza	Data	(GISAID—https	://www.gisaid.org/)
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multiplex	RT-PCR	method	that	amplifies	the	HA,	NA,	and	M	genomic	
segments	 of	 seasonal	 influenza	 A	 and	 B	 viruses	 for	 next-genera-
tion	 sequencing	 was	 used,	 as	 previously	 described.15	 Nucleotide	
sequences	 from	 the	 coding	 regions	 of	 the	HA	 genes	 of	 A(H3N2),	
A(H1N1)pdm09,	and	influenza	B	viruses	were	aligned	using	the	Mafft	
multiple	 aligner	V1.3.7	 in	 the	Geneious	V10.0.9	 software	package	
(www.genei	ous.com).	 Sequences	 originating	 from	 Cambodia,	 sur-
rounding	 countries,	 and	 representative	 reference	 sequences	were	
downloaded	from	the	EpiFlu™	Database	(www.gisaid.org).	Maximum	
likelihood	trees	were	estimated	using	PhyML	3.016	with	1000	boot-







2.7 | Nucleotide sequence accession numbers
All	 Cambodian	 influenza	 A(H3N2),	 A(H1N1)pdm09,	 and	 influenza	
B	 viral	 sequences	 included	 in	 the	 analysis	 were	 submitted	 to	 the	
EpiFlu™	Database,	and	all	of	these	sequences	are	available	via	the	




All	 influenza	 isolates	sent	each	year	 to	the	WHOCC	in	Melbourne	
were	analyzed	for	neuraminidase	 (NA)	 inhibitor	susceptibility	 test-
ing	using	an	enzyme	 inhibition	assay	utilizing	 the	 fluorescent	 sub-
















Trivalent inactivated influenza vaccine strains
Cambodian circulating strainsb 
(proportion of Cambodian isolates)Northern hemispherea Southern hemisphere
2012 A/H1N1pdm09 A/California/7/2009‐like A/California/7/2009‐like A/California/7/2009‐like (100%)
A/H3N2 A/Perth/16/2009-like A/Perth/16/2009-like A/Victoria/361/2011-like	(91%)	 
A/Perth/16/2009-like	(9%)
Influenza	B B/Brisbane/60/2008-like B/Brisbane/60/2008-like B/Wisconsin/1/2010-like	(70%) 
B/Brisbane/60/2008-like	(30%)
2013 A/H1N1pdm09 A/California/7/2009‐like A/California/7/2009‐like A/California/7/2009‐like (100%)
A/H3N2 A/Victoria/361/2011‐like A/Victoria/361/2011‐like A/Victoria/361/2011‐like (100%)
Influenza	B B/Wisconsin/1/2010‐like B/Wisconsin/1/2010‐like B/Wisconsin/1/2010‐like (52%) 
B/Massachusetts/2/2012-like	(43%) 
B/Brisbane/60/2008-like	(5%)
2014 A/H1N1pdm09 A/California/7/2009‐like A/California/7/2009‐like A/California/7/2009‐like (100%)
A/H3N2 A/Victoria/361/2011-like A/Texas/50/2012‐like A/Texas/50/2012‐like (69%) 
A/Victoria/361/2011-like	(30%) 
A/Switzerland/9715293/2013-like	(1%)
Influenza	B B/Massachusetts/2/2012‐like B/Massachusetts/2/2012‐like B/Massachusetts/2/2012‐like (100%)
2015 A/H1N1pdm09 A/California/7/2009‐like A/California/7/2009‐like A/California/7/2009‐like (100%)
A/H3N2 A/Texas/50/2012-like A/Switzerland/9715293/2013‐like A/Switzerland/9715293/2013‐like	(76%) 
A/Hong	Kong/4801/2014-like	(24%)









3.1 | Influenza activity in Cambodia
During	 2012-2015,	 3,222	 specimens	 were	 submitted	 to	 the	
Cambodian	NIC	and	analyzed	as	part	of	the	ILI	surveillance	system	
(Table	1).	Influenza	virus	was	detected	in	1,238	samples	during	this	
period:	 324	 in	2012,	 335	 in	2013,	 263	 in	2014,	 and	316	 in	2015.	
Influenza	A	viruses	(n	=	856,	69.1%)	were	detected	more	frequently	

















Generally,	 Cambodian	 seasonal	 influenza	 virus	 isolates	 matched	
the	 southern	 hemisphere	 trivalent	 inactivated	 influenza	 vac-
cine	 (TIIV)	 formulations	 during	 the	 relevant	 year	 they	 were	 re-
leased	(Table	2).	Antigenic	analysis	revealed	that	all	of	the	A(H1N1)
pdm09	 isolates	 circulating	 in	 Cambodia	 during	 2012-2015	 be-
longed	 to	 the	 A/California/7/2009(H1N1)-like	 group.	 Mismatches	
occurred	 in	 2012	 when	 an	 A/Perth/16/2009(H3N2)-like	 virus	
was	 included	 in	 both	 of	 the	 northern	 and	 southern	 hemisphere	
TIIVs,	 but	A/Victoria/361/2011(H3N2)-like	 viruses	were	 the	domi-
nant	 circulating	 strains;	 also	 in	 2012,	 a	 B/Brisbane/60/2008-like	
virus	 was	 included	 in	 both	 of	 the	 northern	 and	 southern	 hemi-
sphere	 TIIVs,	 but	 B/Wisconsin/1/2010-like	 was	 the	 dominant	
strain;	 in	 2014,	 the	 northern	 hemisphere	 formulation	 of	 TIIVs	 in-
cluded	 an	 A/Victoria/361/2011(H3N2)-like	 virus,	 but	 the	 domi-
nant	 strain	 in	 Cambodia	 was	 A/Texas/50/2012(H3N2)-like	 (which	
















3.4 | Sequence analysis of the matrix gene for 
mutations associated with amantadine resistance






3.5 | Phylogenetic analysis of A(H1N1)
PDm09 Isolates
Phylogenetic	analysis	of	the	HA	gene	sequences	was	carried	out	for	
70	 representative	 Cambodian	 A(H1N1)pdm09	 isolates	 from	 2012	
to	2015	(Figure	3;	GISAID	accession	numbers	are	listed	in	Table	S1).	





which	 was	 isolated	 in	 2012	 and	 grouped	 with	 the	 reference	 strain	
A/Darwin/56/2013	 in	 clade	 6B.2.	 Interestingly,	 three	 Cambodian	
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3.6 | Phylogenetic analysis of A(H3N2) isolates
Phylogenetic	analysis	of	the	HA	gene	sequences	was	carried	out	








two	 viruses	 isolated	 in	 2013	 (A/Cambodia/X0828305/2013	 and	
A/Cambodia/X0906313/2013)	 and	 some	 isolates	 from	 2014;	
clade	3C.3a	contained	most	of	the	isolates	obtained	in	2014;	and	
clade	 3C.2a	 contained	 two	 isolates	 from	 2012	 (A/Cambodia/
W1023355/2012	 and	 A/Cambodia/W0718409/2012),	 some	
isolates	 from	 2013,	 two	 isolates	 from	 2014	 (A/Cambodia/
Y1204313/2014	 and	 A/Cambodia/Y1218307/2014),	 and	 all	 iso-
lates	 obtained	 in	 2015.	 The	 viruses	 in	 clade	 3C.1	 were	 closely	
related	to	 the	vaccine	strain	A/Texas/50/2012.	The	two	 isolates	
from	2013	 and	 some	 isolates	 from	2014	 that	 belonged	 to	 clade	
3C.3b	 contained	 four	 more	 mutations	 compared	 to	 clade	 3C.1.	
The	 Cambodian	 A(H3N2)	 viruses	 isolated	 in	 2014	 diverged	 into	
two	 clades.	 Some	 of	 the	 2014	 viruses	 belonged	 to	 clade	 3C.3b	
with	 the	 reference	 A/Newcastle/22/2014	 strain;	 however,	 the	
majority	 of	 isolates	 from	 2014	 were	 grouped	 with	 the	 vaccine	
strain	A/Switzerland/9715293/2013,	clade	3C.3a.	The	Cambodian	




3.7 | Phylogenetic analysis of influenza B isolates
Phylogenetic	 analysis	 of	 the	 HA	 gene	 sequences	 was	 carried	
out	 for	 56	 representative	 Cambodian	 influenza	 B	 isolates	 from	
2012	 to	 2015	 (Figure	 5;	 GISAID	 accession	 numbers	 and	 listed	
in	Table	S1).	The	Cambodian	 influenza	B	viruses	were	compared	
to	 the	 reference	 strains	 for	B/Yamagata	 (B/Wisconsin/01/2010,	
B/Massachusetts/02/2012,	 and	 B/Phuket/3073/2013),	 and	 B/
Victoria	 (B/Brisbane/60/2008)	 lineages.	 During	 this	 period,	 the	
majority	of	influenza	B	viruses	circulating	in	Cambodia	belonged	to	
the	B/Yamagata-lineage.	However,	Cambodian	influenza	B	isolates	
belonging	 to	 the	B/Victoria-lineage	were	 also	detected	 in	2012,	
2013,	and	2015.	All	of	 the	Cambodian	B/Victoria-lineage	strains	
clustered	with	B/Brisbane/46/2015	(clade	V1.A).	Two	subgroups	
emerged	 within	 the	 Cambodian	 B/Yamagata-lineage.	 One	 sub-
group	(B/Yamagata-lineage,	clade	Y2),	with	most	of	the	Cambodian	
isolates	 collected	 in	 2013	 and	 three	 isolates	 from	 2014,	 was	
closely	 related	 to	 the	 vaccine	 strain	 B/Massachusetts/02/2012.	
The	 other	 subgroup	 of	 Cambodian	 influenza	 B/Yamagata-line-
age	 grouped	 with	 the	 vaccine	 strain	 B/Phuket/3073/2013	 (B/
Yamagata-lineage,	clade	Y3),	which	included	some	of	the	isolates	
collected	 in	 2014	 and	 almost	 all	 isolates	 from	2015.	All	 specific	











2006-20118-10	 revealed	 a	 consistent	 peak	 during	 the	 Cambodian	
rainy	season	from	June	to	November,	which	broadly	coincided	with	
peak	 influenza	 circulation	 in	 the	 southern	 hemisphere.	 However,	
year-round	 co-circulation	 of	multiple	 influenza	 subtypes	 reflected	




However,	 an	 earlier	 peak	 in	 influenza	 circulation	was	 observed	 in	
2014	 (April-August)	 and	 2015	 (June-September),	 which	 coincided	
with	 the	 circulation	 of	 the	 clade	 3C.2a	 and	 3C.3a	 A(H3N2)	 vi-
ruses,	 the	dominant	viruses	 in	 these	seasons,	 respectively.	An	un-
usual,	earlier	peak	in	seasonal	influenza	circulation,	associated	with	
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began	 in	 2006,8,9	 and	 the	 frequent	mismatch	 between	 strains	 in-





Antigenic	 characterization	 of	 Cambodian	 influenza	 isolates	
from	2012	 to	2015	 largely	 corresponded	with	 the	 southern	 and	
northern	 hemisphere	 vaccine	 formulations.	 Vaccination	 for	 sea-
sonal	 influenza	 is	 still	 rare	 in	Cambodia,	with	 vaccines	 generally	
only	 available	 through	 private	 clinics.9,23	 Future	 policies	 for	 the	
introduction	of	seasonal	vaccination	in	Cambodia	will	be	aided	by	
the	distinct	seasonality	of	 influenza	circulation,	which	 is	unusual	
for	 a	 tropical	 country,	 and	 should	 be	 aligned	with	 a	 vaccination	
program	 mirroring	 the	 WHO	 southern	 hemisphere	 vaccination	
formulation	 timetable	 with	 vaccinations	 ideally	 taking	 place	 in	
March-April.	 Recent	 introduction	 of	 seasonal	 alert	 thresholds	 in	
Cambodia24	using	the	“WHO	method”25	will	also	help	to	refine	the	
ideal	vaccination	timing.
There	was	no	detection	of	 seasonal	 influenza	 isolates	with	 re-
sistance	to	the	commonly	used	antivirals	oseltamivir	and	zanamivir	
in	Cambodia	 during	2012-2015.	 These	 antivirals	 are	 generally	 not	
used	in	Cambodia	during	seasonal	influenza	infections,	so	resistance	
is	 unlikely	 to	 be	 affected	 by	 domestic	 antiviral	 use.	 Following	 the	
widespread	reporting	of	adamantane	resistance	in	A(H3N2)	strains	
from	2005	and	the	emergence	of	the	A(H1N1)pdm09	virus	 (which	
was	 already	 adamantane-resistant),	 this	 antiviral	 is	 no	 longer	 rec-
ommended	for	use.26,27	Sequence	analysis	of	the	matrix	gene	from	















included	 in	 these	analyses.	The	 large	number	of	 influenza-positive	
samples	 (n	=	1,238)	 received	by	 the	NIC	during	 this	period	meant	
that	only	representative	isolates	could	be	included	for	genetic	and	





Our	data	 concur	with	 the	 findings	 from	previous	 studies	de-
scribing	the	seasonal	circulation	of	influenza	viruses	in	Cambodia	





the	 influenza	 B	 viruses	 (B/Yamagata-lineage	 viruses	 more	 than	
B/Victoria-lineage	 viruses)	 during	 2012-2015,	 but	 little	 change	





Material	 has	 been	 reviewed	 by	 the	Walter	 Reed	 Army	 Institute	
of	 Research.	 There	 is	 no	 objection	 to	 its	 presentation	 and/or	
publication.	The	opinions	or	 assertions	 contained	herein	are	 the	
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